The University of New England is a public university in Australia with approximately 22,500 higher education students. Its original and main campus is located in the city of Armidale in northern central New South Wales. UNE was the first Australian university established outside a state capital city.

During the past decade, University of New England conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of New England" are "Hypertension" (1 trials) and "Ischemia" (1 trials). Many other conditions were trialed in "University of New England" in a lesser frequency.

Most popular intervention types in "University of New England" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Blood pressure cuff protocol" (1 trials) and "Isometric resistance training" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of New England" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of New England". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of New England, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of New England, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".